tiprankstipranks
Trending News
More News >
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H (HK:9989)
:9989
Hong Kong Market

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H (9989) Revenue

Compare
2 Followers

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H Revenue

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H had a revenue of 1.50B in the quarter ending Sep 30, 2025, with 5.74%. This bring the company's revenue in the last twelve months to 5.53B, Decreased 5.19%. In the fiscal year ending Dec 31, 2024, Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H had annual revenue of 5.28B with -3.03% growth.
Revenue (ttm)
5.53B
Revenue Growth
-1.40%
P/S Ratio
3.33
Revenue/Employee
HK$2,741,803
Employees
1,926
Market Cap
HK$17.56B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
5.28B-164.86M+96.97%
Dec 31, 2023
5.45B-1.71B+76.06%
Dec 31, 2022
7.16B794.23M+112.48%
Dec 31, 2021
6.37B1.03B+119.38%
Dec 31, 2020
5.33B707.42M+115.30%
Dec 31, 2019
4.62B-190.31M+96.05%
Dec 31, 2018
4.81B2.14B+180.32%
Dec 31, 2017
2.67B409.27M+118.10%
Dec 31, 2016
2.26B